Asa and Lanoxin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Asa (aspirin) and Lanoxin (digoxin). Common drug interactions include agitation among females and general physical health deterioration among males.
The phase IV clinical study analyzes what interactions people have when they take Asa and Lanoxin. It is created by eHealthMe based on reports of 77 people who take the same drugs from the FDA, and is updated regularly.
What is Asa?
Asa has active ingredients of aspirin. It is often used in blood clots. eHealthMe is studying from 32,557 Asa users. Check the latest studies of Asa.
What is Lanoxin?
Lanoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 21,852 Lanoxin users. Check the latest studies of Lanoxin.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
77 people who take Asa and Lanoxin together, and have interactions are studied.

What are the common drug interactions of Asa and Lanoxin, by gender? *:
female:
- Agitation (state of anxiety or nervous excitement)
- Back pain
- Balance disorder
- Dyspnoea (difficult or laboured respiration)
- Fatigue (feeling of tiredness)
- Lactic acidosis (low ph in body tissues)
- Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
- Bone disorder
- Diarrhoea
male:
- General physical health deterioration (weak health status)
- Cardiac failure congestive
- Diarrhoea
- Dizziness
- Dyslipidaemia (abnormal amount of lipids)
- Dyspnoea (difficult or laboured respiration)
- Fatigue (feeling of tiredness)
- Renal failure (kidney dysfunction)
- Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands)
- Anaemia (lack of blood)
What are the common drug interactions of Asa and Lanoxin, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Blindness
- Macular degeneration (painless eye condition that leads to the gradual loss of central vision)
- Malaise (a feeling of general discomfort or uneasiness)
- Neoplasm malignant (cancer tumour)
- Anaemia (lack of blood)
- Death
- Drug hypersensitivity
- Febrile neutropenia (fever with reduced white blood cells)
- Klebsiella bacteraemia (klebsiella bacteria in blood after infection to lungs)
- Large intestine perforation (hole in large intestine)
20-29:
n/a
30-39:
- Abscess (pus)
- Activities of daily living impaired
- Agitation (state of anxiety or nervous excitement)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Arrhythmia (irregular heartbeat)
- Arteriosclerosis (thickening and hardening of arteries)
- Arthropathy
- Azotaemia (excess of urea or other nitrogenous compounds in the blood)
- Back pain
40-49:
- Death
- Patient-device incompatibility
- Scleroderma (hard skin)
- Skin tightness
- Tympanic membrane disorder (disease of ear drum)
- Angioedema (rapid swelling of the dermis)
- Blood pressure systolic increased
- Disease progression
- Dysphagia (a condition in which swallowing is difficult or painful)
- Dyspnoea (difficult or laboured respiration)
50-59:
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
- Pneumonitis (inflammation of the walls of the alveoli in the lungs)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Sudden death unexplained
- Vascular resistance systemic decreased
- Cardiac failure congestive
- Atrioventricular block second degree (heart block second degree)
- Cardiac output increased
- Chest discomfort
60+:
- General physical health deterioration (weak health status)
- Cardiac failure congestive
- Arthralgia (joint pain)
- Back pain
- Chest pain
- Diabetes mellitus inadequate control
- Diarrhoea
- Dyslipidaemia (abnormal amount of lipids)
- Dyspnoea (difficult or laboured respiration)
- Renal failure (kidney dysfunction)
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 11 people, 14.29%
- Pain: 5 people, 6.49%
- Hypoglycemia (low blood sugar): 5 people, 6.49%
- Diabetes: 5 people, 6.49%
- Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream): 4 people, 5.19%
- Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 5.19%
- Pressure Ulcer: 4 people, 5.19%
- High Blood Pressure: 4 people, 5.19%
- Cardiac Failure Congestive: 4 people, 5.19%
* Approximation only. Some reports may have incomplete information.
Do you take Asa and Lanoxin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Asa and Lanoxin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Asa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lanoxin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Asa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lanoxin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
- Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .
- Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
- Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
- Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .
- Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
How the study uses the data?
The study uses data from the FDA. It is based on aspirin and digoxin (the active ingredients of Asa and Lanoxin, respectively), and Asa and Lanoxin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lorazepam cause Vascular Access Complication? - 13 seconds ago
- Could Ramipril cause Leukopenia? - 16 seconds ago
- Could Naproxen cause Cardiac Failure Chronic? - 22 seconds ago
- Could Lescol cause Septic Shock? - 23 seconds ago
- Drug interactions of Lamotrigine and Hydromorphone Hydrochloride - 25 seconds ago
- Drug interactions of Tramadol Hydrochloride and Duoneb - 26 seconds ago
- Could Fanapt cause Retrograde Ejaculation? - 28 seconds ago
- Drug interactions of Candesartan Cilexetil and Lanirapid - 29 seconds ago
- Chlorthalidone vs. Omeprazole, side effect and effectiveness comparison - 29 seconds ago
- Could Aricept cause Urinary Incontinence? - 32 seconds ago